Acetylcholinesterase (AChE) is an enzyme that hydrolyzes acetylcholine and thereby regulates the concentration of the transmitter at the cholinergic synapse. AChE is frequently described as a marker of cholinergic neurons in the brain. Several cholinesterase inhibitors have been labeled with carbon-11 as radiotracers for visualizing AChE-binding sites. Among these, carbon-11-labeled methyl-4-piperidyl acetate (MP4A) and methyl-4-piperidyl propionate (MP4P or PMP) are successfully in clinical use for in vivo measurement of AChE activity. Both [11C]MP4A and [11C]PMP opened a window on cerebral cholinergic function in the human brain and have elucidated the role of cholinergic system in Alzheimer's disease, Parkinson's disease, and related disorders.
CITATION STYLE
Shinotoh, H., Hirano, S., & Shimada, H. (2020). PET imaging of acetylcholinesterase. In PET and SPECT of Neurobiological Systems (pp. 193–220). Springer International Publishing. https://doi.org/10.1007/978-3-030-53176-8_7
Mendeley helps you to discover research relevant for your work.